Synthesis of valproic acid amides of a melatonin derivative, a piracetam and amantadine for biological tests

Neurochemical Research

Volumn 26, Issue 10, 2001, Pages 1171-1176

  Chatterjie, Nithiananda ^a   Alexander, George ^a   Wang, Hsin ^b  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Anticonvulsants; Autism; Cognition; Melatonin; Neuroprotection; Valproate

Indexed keywords

AMANTADINE; MELATONIN DERIVATIVE; PIRACETAM; VALPROMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; NERVE INJURY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SPECTROPHOTOMETRY; TREATMENT INDICATION;

AMANTADINE; ANIMALS; MELATONIN; PENTYLENETETRAZOLE; PIRACETAM; RODENTIA; SEIZURES; VALPROIC ACID;

ANIMALIA;

EID: 0034752907     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012383125480     Document Type: Article

References (34)

1. Valproate
2. Valproic acid teratogenesis
3. Valproic acid induced neural tube defects in mouse and human: Aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms
4. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism
5. Pharmacologic evaluation of various metabolites and analogs of valproic acid: Teratogenic potencies in mice
6. Anticonvulsant and neurotoxic activities of twelve analogs of valproic acid
7. Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect
8. Pharmacological evaluation of various metabolites and analogues of valproic acid. Anticonvulsant and toxic potencies in mice
9. Structure pharmacokinetic relationships in a series of valpromide derivatives with anti-epileptic activity
10. Structure pharmacokinetic relationships in a series of short fatty acid amides that possess anticonvulsant activity
11. Weak acids may act as teratogens by accumulating in the basic milieu of the early mammalian embryo
12. Teratogenicity of valproic acid and related substances in the mouse: Drug accumulation and pHi in the embryo during organogenesis and structure-activity considerations
13. Synthesis and pharmacological activity of two derivatives of the amide of valproic acid
14. Bonded pharmacophores show striking prolongation of effects
15. Valproylmelatonin: A long-acting anticonvulsant
16. Amphetamine-naloxone interaction: Prolonged protection by naloxyl-6-alpha-spirohydantoin
17. Synthesis and chemistry of melatonin and related compounds. A review
18. Anticonvulsant effects of melatonin in amygdala-kindled rats
19. Melatonin in epilepsy: First results of replacement therapy and first clinical results
20. On the effect of melatonin upon human brain: Its possible therapeutic implications
21. Neuroprotection by melatonin from glutamate-induced excitotoxicity during development of the cerebellum in the chick embryo
22. New anti-epileptic drugs for the 21-st Century
23. Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents-preclinical studies
24. Psychotogenicity and N-methyl-D-aspartate receptor antagonism: Implications for neuroprotective pharmacotherapy
25. The increase of seizures among children with autistic symptoms
26. Epilepsy in the developing brain, lessons from the laboratory and clinic
27. Cognitive correlation of interictal discharges
28. The irreversible gamma-aminobutyric acaid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats
29. Mental and behavioral outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients
30. Treatment of epilepsy in autism
31. Valproic acid treatment of epilepsy in autistic twins
32. Epilepsy and epileptiform EEG: Association with autism and language disorders
33. Treatment of seizure disorders and EEG abnormalities in children with autism spectrum disorders
34. Stereoselective inhibition of dopaminergic activity by gamma vinyl-GABA following a nicotine or cocaine challenge: A pet/microdialysis study